Plus Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 2.28 M | $1.17 M | 57.55% | 2.12% |
| 02/13/2026 | 2.28 M | $1.17 B | 100.00% | 2.12% | |
| BLACKROCK, INC. | 02/12/2026 | 1.78 M | $910.04 M | 278.44% | 1.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.40 M | $719.03 M | 72.49% | 1.31% |
| JANE STREET GROUP, LLC | 02/12/2026 | 1.02 M | $524.55 M | 100.00% | 0.95% |
| UBS GROUP AG | 01/29/2026 | 875.85 K | $448.43 M | 40.39% | 0.82% |
| STATE STREET CORP | 02/13/2026 | 468.89 K | $240.21 K | 37.15% | 0.44% |
| XTX TOPCO LTD | 02/17/2026 | 248.56 K | $127.34 M | 100.00% | 0.23% |
| CITADEL ADVISORS LLC | 02/17/2026 | 185.06 K | $94.80 M | 100.00% | 0.17% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 55.88 K | $28.63 K | 404.45% | 0.05% |
| CITIGROUP INC | 02/13/2026 | 48.46 K | $24.82 K | 100.00% | 0.05% |
| DAGCO, INC. | 01/08/2026 | 25.88 K | $13.26 K | 0.00% | 0.02% |
| KESTRA ADVISORY SERVICES, LLC | 02/13/2026 | 25.80 K | $13.22 M | 0.00% | 0.02% |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 01/29/2026 | 24.91 K | $12.76 K | 100.00% | 0.02% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 16.00 K | $8.20 K | 100.00% | 0.01% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/05/2026 | 13.45 K | $7.00 K | 28.10% | 0.01% |
| J.W. COLE ADVISORS, INC. | 02/11/2026 | 10.00 K | $5.12 K | 100.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 1.84 K | $944.00 K | -44.90% | 0.00% |
| ROYAL BANK OF CANADA | 02/17/2026 | 1.40 K | $1.00 K | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.27 K | $648 | 52.23% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 133 | $67.00 K | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 53 | $27 | 0.00% | 0.00% |
| SOUND INCOME STRATEGIES, LLC | 01/21/2026 | 28 | $8 | 100.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 2 | $1 | 0.00% | 0.00% |
| DANSKE BANK A/S | 02/02/2026 | 1 | $1 | 0.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 02/18/2026 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/06/2026 | 0 | $0 | -100.00% | 0.00% |
| SCIENTECH RESEARCH LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Plus Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of Plus Therapeutics Inc. The most heavily invested institutionals were:
VANGUARD GROUP INC: 2.28 M
BlackRock, Inc.: 1.78 M
GEODE CAPITAL MANAGEMENT, LLC: 1.4 M
JANE STREET GROUP, LLC: 1.02 M
UBS Group AG: 875,846
STATE STREET CORP: 468,893
9.56% of Plus Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 8.50 M shares in the last 24 months. This purchase volume represents approximately $2.38 M in transactions.